CytoSorbents Corp. (CTSO)

6.06
NASDAQ : Health Technology
Prev Close 5.92
Day Low/High 5.84 / 6.10
52 Wk Low/High 5.86 / 14.95
Avg Volume 117.10K
Exchange NASDAQ
Shares Outstanding 32.25M
Market Cap 190.91M
EPS -0.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

CytoSorbents To Report Q1 2019 Operating And Financial Results

CytoSorbents To Report Q1 2019 Operating And Financial Results

MONMOUTH JUNCTION, N.J.

CytoSorbents Achieves Record Revenue And Product Sales Growth In 2018

CytoSorbents Achieves Record Revenue And Product Sales Growth In 2018

2018 Total Revenue was $22.5 million, with 2018 Product Sales surpassing $20M for the first time, representing 51% growth over 2017

CytoSorbents To Present At The Cowen 39th Annual Health Care Conference

CytoSorbents To Present At The Cowen 39th Annual Health Care Conference

MONMOUTH JUNCTION, N.J.

CytoSorbents To Report Fiscal 2018 Operating And Financial Results

CytoSorbents To Report Fiscal 2018 Operating And Financial Results

MONMOUTH JUNCTION, N.J.

CytoSorbents To Present At The 21st Annual BIO CEO & Investor Conference

CytoSorbents To Present At The 21st Annual BIO CEO & Investor Conference

MONMOUTH JUNCTION, N.J.

CytoSorbents Announces Expansion Of CytoSorb® Partnership With Fresenius Medical Care

CytoSorbents Announces Expansion Of CytoSorb® Partnership With Fresenius Medical Care

Agreement brings innovative CytoSorb® therapy to Korea and Mexico and sets the stage for future growth

CytoSorbents Issues Stockholder Letter With Preliminary 2018 Financial Results

CytoSorbents Issues Stockholder Letter With Preliminary 2018 Financial Results

CytoSorbents achieved another year of record growth with total revenue of more than $22.3 million, including product sales of approximately $20.2 million, a 51% increase from a year ago

CytoSorbents To Highlight Progress At Biotech Showcase 2019

CytoSorbents To Highlight Progress At Biotech Showcase 2019

MONMOUTH JUNCTION, N.J.

Cytosorbents Enters Oversold Territory (CTSO)

Cytosorbents Enters Oversold Territory (CTSO)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Cytosorbents CEO on How to Avoid the Flu and 'Cytokine Storms'

Cytosorbents CEO on How to Avoid the Flu and 'Cytokine Storms'

Last year 80,000 people died from the flu - making it the most dangerous season in more than four decades.

CTSO Crosses Above Key Moving Average Level

CTSO Crosses Above Key Moving Average Level

In trading on Wednesday, shares of Cytosorbents Corp crossed above their 200 day moving average of $10.12, changing hands as high as $10.16 per share. Cytosorbents Corp shares are currently trading up about 6% on the day.

General Electric's Stock Is Attractive for the First Time in 2 Years: Jim Cramer

General Electric's Stock Is Attractive for the First Time in 2 Years: Jim Cramer

Jim Cramer says earnings could break the tie between the bulls and the bears -- unless China blinks. Here's the game plan for next week.

Interesting CTSO Put And Call Options For February 2019

Interesting CTSO Put And Call Options For February 2019

Investors in Cytosorbents Corp saw new options begin trading this week, for the February 2019 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 235 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Cytosorbents Enters Oversold Territory (CTSO)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Oversold Conditions For Cytosorbents

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Oversold Conditions For Cytosorbents (CTSO)

Oversold Conditions For Cytosorbents (CTSO)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Immunotherapies Will Grow in 2016; Fighting Inflammation Is Key -- CytoSorbents CEO

Immunotherapies Will Grow in 2016; Fighting Inflammation Is Key -- CytoSorbents CEO

Immunotherapy was one of the hottest -- and most crowded -- areas within biotech in 2015. And 2016 looks promising.

Blood Therapy Device Will Win Big in 2016 Says CytoSorbents CEO

Blood Therapy Device Will Win Big in 2016 Says CytoSorbents CEO

Immunotherapy was one of the hottest – and most crowded - areas within biotech in 2015.

5 Breakout Stocks Under $10 Set to Soar

5 Breakout Stocks Under $10 Set to Soar

These under-$10 stocks look ready to break out and trade higher from current levels.